We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medica Group Plc | LSE:MGP | London | Ordinary Share | GB00BYV24996 | ORD 0.2P |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
- |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
- | O | 0 | 211.00 | GBX |
Date | Time | Source | Headline |
---|---|---|---|
07/7/2023 | 08:00 | UKREG | London Stock Exchange Notice Cancellation - Medica Group plc |
07/7/2023 | 07:30 | UKREG | Medica Group PLC De-listing and Cancellation of Trading of Shares |
06/7/2023 | 15:29 | UKREG | Credit Industriel et Commercial Form 8.3 - Medica Group plc |
06/7/2023 | 15:25 | UKREG | MILLENNIUM PARTNERS: Form 8.3 - Medica Group plc |
06/7/2023 | 15:00 | UKREG | GWM Asset Management Limited Form 8.3 - Medica Group PLC |
06/7/2023 | 13:28 | UKREG | Medica Group PLC Holding(s) in Company |
06/7/2023 | 10:26 | UKREG | Rule 8.3 - Medica Group Plc |
06/7/2023 | 10:01 | UKREG | Medica Group PLC Scheme of Arrangement becomes Effective |
06/7/2023 | 09:32 | UKREG | Jefferies International Limited. Form 8.5 (EPT/NON-RI) Medica Group Plc |
06/7/2023 | 09:18 | UKREG | Numis Securities Limited Form 8.5 (EPT/RI) - Medica Group Plc |
Medica (MGP) Share Charts1 Year Medica Chart |
|
1 Month Medica Chart |
Intraday Medica Chart |
Date | Time | Title | Posts |
---|---|---|---|
19/7/2023 | 15:46 | Medica Group | 845 |
04/8/2009 | 13:33 | Mercury Group: Charts and Comment | 254 |
24/7/2008 | 15:11 | Mercury Group...A New Beginning. | 668 |
14/10/2005 | 17:59 | Mercury Group (Old Cater Barnard) A New Beginning | 254 |
16/4/2004 | 07:53 | Make My Day | 5 |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|
Top Posts |
---|
Posted at 19/7/2023 15:18 by ali47fish the amount was not correct for me - is thrh takeover price 212 |
Posted at 08/5/2023 13:51 by alphafund Thanks for that - I should have started reading backwards the takeover offer, was on the past page! So from memory they have 28 Days to lodge their Scheme Document unless extended, so we 1/2 way there now, on day 14, with another 2M share traded over the buy price, so we be around 20M share changed hands. |
Posted at 05/5/2023 07:18 by alphafund No further discussion here - its interesting that at least $16 shares or over 10% of the market cap has changed hands at or above the offer price - me things there will be certainly be a push for a higher offer.I can't find the chat on Stockopedia, don't know the site and no a member, is there any chatter about competing bids? |
Posted at 24/4/2023 10:10 by irenekent Not much more than I paid for them back in the day. Not a great price. Hope for an alternative & better offer. |
Posted at 24/4/2023 07:58 by ali47fish mgp takeover offer 212p up 31pc today |
Posted at 24/4/2023 07:29 by 18bt Another market leading British company taken over by private equity. I'm running out of companies on the market I really want to invest in. Not very happy about the price - 32% premium to an undervalued price. |
Posted at 17/1/2023 14:56 by mighunter Love how quiet this share is. Particularly pleased with 16% increase in capacity following recruitment. Suspect it won't be difficult to fill! |
Posted at 17/1/2023 12:56 by kalai1 Medica Group plc issued a trading update for FY22 and an outlook for FY23 this morning. Medica had a strong performance for the second half of the year across the Group driven in particular by UK Elective revenues returning to expected levels. Group revenue of £77.0 million for the twelve-month period ending 31 December 2022 was in-line with market expectations and represents an increase of 24% over 2021. Gross margins also remained resilient at 48%, operating profit is expected in line with expectations. The balance sheet is solid, Medica had £0.5 million of net cash at 31 December 2022. Medica continues to evaluate strategic acquisition opportunities to expand the scale and therapeutic focus of its clinical trials business, as well as to accelerate wider growth and differentiation of the business while also continuing to focus on new areas of organic growth. Valuation is attractive, profitability is high and the business has a solid history of growth. BUY......from WealthOracle |
Posted at 17/10/2022 10:55 by stun12 c34, I see that Lombard Odier increased their SBI holding to over 26%. They must like the sector. SBI share price has been as dull as ditchwater for a few months, not that that's a bad thing necessarily in the current market. |
Posted at 01/8/2022 16:14 by rob the slob Boonkoh, your question has been partly answered I guess by todays RNS? The answer being major institutional investor has INCREASED their holding to over 17%, with over 5% of the company shares changing hands in these trades. A reminder that "selling down" could equally mean "buying up"! Especially when the share price doesn't move as it didn't. We should get another RNS in the next few days from the seller or sellers as you can't just buy 6M+ of these shares in the open market given the average traded volumes. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions